Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device

Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device

[at noodls] – PLAINSBORO, N.J., Oct. 9, 2012 (GLOBE NEWSWIRE) — Integra® LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Food and Drug Administration (FDA) has approved an expanded indication … more

View todays social media effects on IART

View the latest stocks trending across Twitter. Click to view dashboard

Share this post